Finance

Lists
Why is 301089 up 3,72%?
Dive Deeper
301089:SHE
Tuoxin Pharmaceutical Group Co Ltd
23,70 CNY
+3,72%
(+0,85) 1D
16 ოქტ, 15:04:04 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301089...
Open
23,24 CNY
High
25,28 CNY
Low
22,88 CNY
Mkt. cap
3,01 მლრდ.
Avg. vol.
1,94 მლნ.
Volume
5,39 მლნ.
52-wk high
36,34 CNY
52-wk low
19,33 CNY
EPS
-0,63 CNY
Shares outstanding
126,54 მლნ.
No. of employees
2 ათ.
Open
23,24 CNY
High
25,28 CNY
Low
22,88 CNY
Mkt. cap
3,01 მლრდ.
Avg. vol.
1,94 მლნ.
Volume
5,39 მლნ.
52-wk high
36,34 CNY
52-wk low
19,33 CNY
EPS
-0,63 CNY
Shares outstanding
126,54 მლნ.
No. of employees
2 ათ.
News stories
From web sources and news partners
www.pei-privaterealestate.com
www.pei-privaterealestate.com
·
13 წუთის წინ
NASDAQ report tracks insurer shift toward real estate debt strategies in 2025
Investing News Network
Investing News Network
·
1 საათის წინ
BCRF Launches $100 Million Venture Program for Breast Cancer: NYSE Content Update
Forbes
Forbes
·
11 წუთის წინ
SK Hynix Opened Nasdaq. Will Seoul Keep It Open?
Yahoo Finance
Yahoo Finance
·
25 წუთის წინ
Nasdaq Reports Network Disruption Affecting US Equities Data Feeds
About Tuoxin Pharmaceutical Group Co Ltd
CEO-
Employees1,54 ათ.
Founded2001
Headquarters-
SectorPharmaceutical industry
Websitetuoxinpharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
89,65 მლნ.
106,79 მლნ.
92,50 მლნ.
118,80 მლნ.
Cost of goods sold
65,50 მლნ.
105,13 მლნ.
69,98 მლნ.
107,19 მლნ.
Cost of revenue
65,50 მლნ.
105,13 მლნ.
69,98 მლნ.
107,19 მლნ.
Research and development expenses
10,17 მლნ.
11,51 მლნ.
9,42 მლნ.
11,65 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
29,58 მლნ.
22,34 მლნ.
21,84 მლნ.
19,91 მლნ.
Operating expense
41,60 მლნ.
49,49 მლნ.
31,34 მლნ.
33,81 მლნ.
Total operating expenses
107,10 მლნ.
154,61 მლნ.
101,31 მლნ.
141,00 მლნ.
Operating income
-17,45 მლნ.
-47,82 მლნ.
-8,81 მლნ.
-22,20 მლნ.
Other non operating income
-410,47 ათ.
330,46 ათ.
-510,80 ათ.
397,00 ათ.
EBT including unusual items
-15,08 მლნ.
-35,88 მლნ.
-13,46 მლნ.
-15,22 მლნ.
EBT excluding unusual items
-16,16 მლნ.
-46,84 მლნ.
-9,04 მლნ.
-21,98 მლნ.
Income tax expense
-3,20 მლნ.
3,62 მლნ.
-2,95 მლნ.
2,23 მლნ.
Effective tax rate
21,21%
-10,10%
21,92%
-14,66%
Other operating expenses
1,79 მლნ.
2,50 მლნ.
1,71 მლნ.
1,99 მლნ.
Net income
-11,88 მლნ.
-39,50 მლნ.
-10,51 მლნ.
-17,45 მლნ.
Net profit margin
-13,25%
-36,99%
-11,36%
-14,69%
Earnings per share
-
-
-
-
Interest and investment income
1,76 მლნ.
1,28 მლნ.
317,62 ათ.
772,07 ათ.
Interest expense
-37,84 ათ.
-31,10 ათ.
-31,40 ათ.
-32,11 ათ.
Net interest expenses
1,73 მლნ.
1,25 მლნ.
286,22 ათ.
739,96 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,61 მლნ.
-31,49 მლნ.
7,52 მლნ.
-2,93 მლნ.
Gain or loss from assets sale
-
416,39 ათ.
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები